Pancreatic Cancer Research

ResearcherHeidelberg UniversityActive in the last 2 years

Fabio F. di Mola

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9877-2946; OpenAlex author ID A5010675355. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
46
Papers, trials and grants by year

2012: 3 papers · 2013: none · 2014: 2 papers · 2015: 2 papers · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 11

  1. Pancreatic cancer surgery in Italy: an updated snapshot from a national multicentre analysis of outcomes by hospital volume. Co-author DOI 10.1007/s13304-026-02813-5↗
  2. Could the Microbial Profiling of Normal Pancreatic Tissue from Healthy Organ Donors Contribute to Understanding the Intratumoral Microbiota Signature in Pancre… Co-author DOI 10.3390/microorganisms13020452↗
  3. High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Patients with Pancreatic Cancer: Results f… Co-author DOI 10.3390/cancers14194748↗
  4. Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy. Last author DOI 10.1007/s13304-016-0392-x↗
  5. BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages. Co-author DOI 10.1038/ncomms9695↗
  6. SIRT1 and circadian gene expression in pancreatic ductal adenocarcinoma: Effect of starvation. Co-author DOI 10.3109/07420528.2014.1003351↗
  7. A tumour score with multidetector spiral CT for venous infiltration in pancreatic cancer: influence on borderline resectable. Last author DOI 10.1007/s11547-013-0349-9↗
  8. Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clini… Co-author DOI 10.1186/s12967-014-0248-4↗
  9. Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival. Co-author DOI 10.1016/j.ajpath.2012.07.016↗
  10. Correlations among PPARγ, DNMT1, and DNMT3B Expression Levels and Pancreatic Cancer. Co-author DOI 10.1155/2012/461784↗
  11. Time-Qualified Patterns of Variation of PPARγ, DNMT1, and DNMT3B Expression in Pancreatic Cancer Cell Lines. Co-author DOI 10.1155/2012/890875↗

Closest collaborators

The 25 strongest of 46 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Pierluigi Di Sebastiano · 9 shared papers, 2012–2022 · strength 0.44
  2. Francesca Tavano · 7 shared papers, 2012–2025 · strength 0.42
  3. Francesco Perri · 1 shared paper, 2025 · strength 0.22
  4. Tommaso Mazza · 1 shared paper, 2025 · strength 0.22
  5. Tiziana Pia Latiano · 1 shared paper, 2025 · strength 0.22
  6. Andrea Fontana · 5 shared papers, 2012–2015 · strength 0.17
  7. Angelo Andriulli · 4 shared papers, 2012–2015 · strength 0.14
  8. Valerio Pazienza · 4 shared papers, 2012–2015 · strength 0.14
  9. Nicola Tinari · 1 shared paper, 2022 · strength 0.11
  10. Davide Brocco · 1 shared paper, 2022 · strength 0.11
  11. Rosalba Florio · 1 shared paper, 2022 · strength 0.11
  12. Laura De Lellis · 1 shared paper, 2022 · strength 0.11
  13. Alessandro Cama · 1 shared paper, 2022 · strength 0.11
  14. Paola Lanuti · 1 shared paper, 2022 · strength 0.11
  15. Serena Veschi · 1 shared paper, 2022 · strength 0.11
  16. Lucia Lombardi · 2 shared papers, 2014–2015 · strength 0.08
  17. Gianluigi Mazzoccoli · 2 shared papers, 2012–2015 · strength 0.07
  18. Alessandra Rosati · 2 shared papers, 2012–2015 · strength 0.06
  19. Vincenzo De Laurenzi · 2 shared papers, 2012–2015 · strength 0.06
  20. Maria Caterina Turco · 2 shared papers, 2012–2015 · strength 0.06
  21. Margot De Marco · 2 shared papers, 2012–2015 · strength 0.06
  22. Francesco Giuliani · 1 shared paper, 2015 · strength 0.04
  23. Concetta Panebianco · 1 shared paper, 2015 · strength 0.04
  24. Tiziana Marinelli · 1 shared paper, 2014 · strength 0.04
  25. Markus Wolfgang Büchler · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.